[1]葛盘春.阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效[J].医学信息,2022,35(06):135-137.[doi:10.3969/j.issn.1006-1959.2022.06.034]
　GE Pan-chun.Clinical Efficacy of Amoxicillin and Clavulanate Potassium in the Treatment of Pneumonia in Children[J].Medical Information,2022,35(06):135-137.[doi:10.3969/j.issn.1006-1959.2022.06.034]
点击复制

阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年06期
页码:
135-137
栏目:
临床研究
出版日期:
2022-03-15

文章信息/Info

Title:
Clinical Efficacy of Amoxicillin and Clavulanate Potassium in the Treatment of Pneumonia in Children
文章编号:
1006-1959（2022）06-0135-03
作者:
葛盘春
（天津市滨海新区大港医院儿科，天津 300270）
Author(s):
GE Pan-chun
(Department of Pediatric,Dagang Hospital of Binhai New Area,Tianjing 300270,China)
关键词:
阿莫西林克拉维酸钾; 肺炎; 肺功能
Keywords:
Amoxicillin and clavulanate potassium; Pneumonia; Lung function
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2022.06.034
文献标志码:
A
摘要:
目的 探讨阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效及安全性。方法 选取2018年5月-2019年5月我院诊治的102例儿童肺炎患者为研究对象，采用随机数字表法分为对照组和观察组，各51例。对照组采用阿莫西林治疗，观察组采用阿莫西林克拉维酸钾治疗，比较两组临床疗效、临床症状消退时间、临床症状评分、肺功能指标[第1秒用力呼气容积（FEV1）、用力肺活量（FVC）]、不良反应发生情况。结果 观察组治疗总有效率为96.08%，高于对照组的86.27%，差异有统计学意义（P＜0.05）；观察组发热、咽喉肿痛、扁桃体充血、咳嗽、肺部啰音消退时间短于对照组，差异有统计学意义（P＜0.05）；观察组咳嗽、咳痰、憋喘症状评分低于对照组，差异有统计学意义（P＜0.05）；两组治疗后FEV1、FVC水平高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 阿莫西林克拉维酸钾治疗儿童肺炎具有良好的治疗效果，可有效改善临床症状及肺功能，且不良反应少，安全性高。
Abstract:
Objective To investigate the clinical efficacy and safety of amoxicillin and clavulanate potassium in the treatment of pneumonia in children.Methods A total of 102 children with pneumonia who were treated in our hospital from May 2018 to May 2019 were selected as subjects. They were divided into control group and observation group by random number table method, 51 cases in each group. The control group was treated with amoxicillin, and the observation group was treated with amoxicillin and clavulanate potassium. The clinical efficacy, clinical symptom regression time, clinical symptom score, pulmonary function indexes [forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC)] and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 96.08%, which was higher than 86.27% of the control group, and the difference was statistically significant (P<0.05). The time of fever, sore throat, tonsil congestion, cough and pulmonary rales in the observation group was shorter than that in the control group, and the difference was statistically significant (P<0.05). The scores of cough, expectoration and asthma in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05). The scores of cough, expectoration and asthma in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05).Conclusion Amoxicillin and clavulanate potassium in the treatment of pneumonia in children has good therapeutic effect, which can effectively improve clinical symptoms and lung function, with less adverse reactions and high safety.

参考文献/References:

[1]董德兴,赵欣.阿莫西林/克拉维酸钾联合阿奇霉素治疗小儿肺炎及对肠道微生态的影响[J].吉林医学,2021,42(8):1907-1909.[2]梁兵.间歇超声雾化吸入在儿童肺炎治疗中的应用[J].中国药物经济学,2017,12(8):120-122.[3]白秀堂.阿奇霉素联合头孢呋辛钠加氨溴索治疗儿童肺炎支原体肺炎临床观察[J].中国药物与临床,2017,17(11):1676-1678.[4]毛国辉.阿奇霉素联合布地奈德混悬液与沙丁胺醇雾化吸入治疗小儿肺炎支原体肺炎疗效与安全性评价[J].蚌埠医学院学报,2017,42(8):1100-1102.[5]张建梅,周金芳,王敏,等.阿奇霉素、孟鲁司特钠联合普米克令舒治疗对支原体肺炎儿童炎症程度、肺功能的影响[J].海南医学院学报,2016,22(18):2171-2173,2177.[6]蔡惠东,潘剑蓉.阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的疗效评价[J].检验医学与临床,2017,14(17):2590-2592.[7]滕丽荣,李小村,路兴志,等.肺炎支原体肺炎后反复呼吸道感染儿童的免疫功能及临床意义[J].中国妇幼保健,2017,32(22):5613-5615.[8]于春琳,赵德育.肺炎支原体肺炎免疫功能与其病情的相关性[J].江苏医药,2017,43(19):1388-1390.[9]刘金,闫虹,陈小庚,等.槐杞黄颗粒对重型肺炎支原体肺炎患儿免疫功能的影响[J].中国当代儿科杂志,2017,19(7):759-762.[10]赵爱利.吉他霉素治疗小儿肺炎支原体肺炎的疗效及对血清相关炎症细胞因子的影响[J].中国妇幼保健,2017,32(19):4713-4716.[11]丁石头生.阿莫西林-克拉维酸钾与阿奇霉素对小儿支气管肺炎的临床疗效评价[J].抗感染药学,2018,15(1):178-180.[12]赵晓玲,夏燕,袁泽芹.阿莫西林克拉维酸钾或头孢他啶联合布地奈德对肺炎患儿的疗效[J].中国微生态学杂志,2021,33(1):62-65,70.[13]周琳,石磊,石焱.阿奇霉素治疗儿童肺炎支原体肺炎疗效观察[J].临床军医杂志,2018,46(6):688-689.[14]陈玲,覃军,胡荆江.糖皮质激素在治疗儿童急重症肺炎中的应用及对C-反应蛋白的影响分析[J].河北医药,2016,38(11):1608-1610.[15]权艳红.阿奇霉素联合阿莫西林克拉维酸钾治疗儿童肺炎效果分析[J].青岛医药卫生,2021,53(3):169-172.[16]Huttner A,Bielicki J,Clements MN,et al.Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage[J].Clin Microbiol Infect,2020,26(7):871-879.[17]Lipsett SC,Hall M,Ambroggio L,et al.Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia[J].J Pediatr,2021(229):207-215.e1.[18]李万琼.阿奇霉素联合布地奈德混悬液雾化吸入治疗小儿肺炎支原体肺炎体会[J].贵州医药,2016,40(10):1080-1081.[19]胡汉军,叶志华.阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效及安全性分析[J].中国医刊,2015,50(2):104-106.[20]王明霞.阿莫西林克拉维酸钾治疗儿童肺炎的疗效与安全性分析[J].中国卫生标准管理,2016,7(12):92-93.

相似文献/References:

[1]李绪定.碳青霉烯类治疗铜绿假单胞菌肺炎的临床效果分析[J].医学信息,2018,31(13):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
　LI Xu-ding.Clinical Effect of Carbapenem in the Treatment of Pseudomonas Aeruginosa Pneumonia[J].Medical Information,2018,31(06):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
[2]远 颖.黄芪注射液治疗儿童肺炎的Meta分析[J].医学信息,2019,32(02):95.[doi:10.3969/j.issn.1006-1959.2019.02.027]
　YUAN Ying.Meta-analysis of Huangqi Injection in the Treatment of Children with Pneumonia[J].Medical Information,2019,32(06):95.[doi:10.3969/j.issn.1006-1959.2019.02.027]
[3]曾小兰.阿莫西林-克拉维酸钾、左氧氟沙星治疗下呼吸道感染的疗效及成本-效果分析[J].医学信息,2022,35(18):77.[doi:10.3969/j.issn.1006-1959.2022.18.019]
　ZENG Xiao-lan.Efficacy and Cost-effectiveness Analysis of Amoxicillin-clavulanate Potassium and Levofloxacin in Treatment of Lower Respiratory Tract Infection[J].Medical Information,2022,35(06):77.[doi:10.3969/j.issn.1006-1959.2022.18.019]
[4]易晓明,曾 芬.甲泼尼龙治疗SCAP的效果及其对降钙素原水平的影响[J].医学信息,2019,32(21):145.[doi:10.3969/j.issn.1006-1959.2019.21.047]
　YI Xiao-ming,ZENG Fen.Effect of Methylprednisolone on SCAP and its Effect on Procalcitonin Level[J].Medical Information,2019,32(06):145.[doi:10.3969/j.issn.1006-1959.2019.21.047]
[5]阳池娇,陈进喜,白 珺.儿童7型腺病毒肺炎特点分析[J].医学信息,2020,33(02):121.[doi:10.3969/j.issn.1006-1959.2020.02.035]
　YANG Chi-jiao,CHEN Jin-xi,BAI Jun.Characteristics Analysis of Adenovirus Type 7 Pneumonia in Children[J].Medical Information,2020,33(06):121.[doi:10.3969/j.issn.1006-1959.2020.02.035]
[6]于 波.静脉注射丙种球蛋白治疗早产儿肺炎临床疗效[J].医学信息,2020,33(04):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
　YU Bo.Clinical Efficacy of Intravenous Gamma Globulin in Premature Infants with Pneumonia[J].Medical Information,2020,33(06):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
[7]郭 婷,张思琪.2019年12月~2020年3月新型冠状病毒肺炎主题研究的文献计量学分析[J].医学信息,2020,33(12):1.[doi:10.3969/j.issn.1006-1959.2020.12.001]
　GUO Ting,ZHANG Si-qi.Bibliometric Analysis of the Theme Research on Novel Coronavirus Pneumonia from December 2019 to March 2020[J].Medical Information,2020,33(06):1.[doi:10.3969/j.issn.1006-1959.2020.12.001]
[8]蔡文斌.阿莫西林克拉维酸钾联合雾化吸入治疗小儿支气管肺炎的效果及对PCT、CRP的影响[J].医学信息,2022,35(19):68.[doi:10.3969/j.issn.1006-1959.2022.19.018]
　CAI Wen-bin.Effect of Amoxicillin and Clavulanate Potassium Combined with Aerosol Inhalation on Children with Bronchial Pneumonia and Its Influence on PCT and CRP[J].Medical Information,2022,35(06):68.[doi:10.3969/j.issn.1006-1959.2022.19.018]
[9]黄永辉,吕 刚.纤维支气管镜下注入依替米星治疗脑卒中后肺炎的疗效[J].医学信息,2020,33(15):146.[doi:10.3969/j.issn.1006-1959.2020.15.046]
　HUANG Yong-hui,LYU Gang.Efficacy of Injecting Etimicin under Fiberoptic Bronchoscopein the Treatment of Pneumonia After Stroke[J].Medical Information,2020,33(06):146.[doi:10.3969/j.issn.1006-1959.2020.15.046]
[10]马 斌,柴 智,王金虹.基于CNKI的中医诊断冠状病毒肺炎研究的文献计量学分析[J].医学信息,2020,33(21):4.[doi:10.3969/j.issn.1006-1959.2020.21.002]
　MA Bin,CHAI Zhi,WANG Jin-hong.Bibliometric Analysis of Research Literature on Diagnosis of Coronavirus Pneumonia in Chinese Medicine Based on CNKI[J].Medical Information,2020,33(06):4.[doi:10.3969/j.issn.1006-1959.2020.21.002]

更新日期/Last Update: 1900-01-01